BOEHRINGER INGELHEIM ANIMAL HEALTH H-1B salaries (2026)
Yes — BOEHRINGER INGELHEIM ANIMAL HEALTH sponsors H-1B workers. Across 13 certified Labor Condition Applications, the median offered base wage is $130,000. Every figure below comes straight from the employer's own filings with the U.S. Department of Labor.
BOEHRINGER INGELHEIM ANIMAL HEALTH filed 13 certified H-1B labor condition applications across 3 states between Feb 2025 and Mar 2026. The median offered base wage was $130,000.
- Median offered wage
- $130,000
- Certified filings
- 13
- Work locations
- 3 states
- Distinct roles
- 12
Most-filed roles at BOEHRINGER INGELHEIM ANIMAL HEALTH
| Role | Filings | Median wage |
|---|---|---|
| Senior Scientist, Clinical | 2 | $153,149 |
| Associate Director, Ecosystem Operations Management | 1 | $195,000 |
| Director, Late Stage Drug Product Development | 1 | $222,750 |
| Post Doctoral Fellow | 1 | $80,000 |
| Principal Specialist, Validation | 1 | $120,000 |
| Product Portfolio Manager | 1 | $151,526 |
| Scientist Iv | 1 | $143,252 |
| Scientist Iv, Avian Virology | 1 | $130,000 |
| Scientist Iv, Bioanalysis | 1 | $118,501 |
| Scientist Iv, Clinical | 1 | $130,000 |
| Senior Specialist, Qa Release | 1 | $75,000 |
| Specialist, Lyo Equipment | 1 | $90,000 |
Wage-level distribution
DOL prevailing-wage levels reflect the seniority the employer certified, from Level I (entry) to Level IV (fully competent).
| Level | Filings | Median wage |
|---|---|---|
| Level I — entry | 1 | $80,000 |
| Level II — qualified | 3 | $130,000 |
| Level III — experienced | 3 | $151,526 |
| Level IV — fully competent | 6 | $144,126 |
Where BOEHRINGER INGELHEIM ANIMAL HEALTH hires
| State | Filings | Median wage |
|---|---|---|
| Georgia | 8 | $147,389 |
| Missouri | 4 | $104,250 |
| Iowa | 1 | $145,000 |
Recent certified filings
| Job title | Location | Wage | Level | Decided |
|---|---|---|---|---|
| Principal Specialist, Validation | Athens, Georgia | $120,000 | IV | Mar 2026 |
| Associate Director, Ecosystem Operations Management | Duluth, Georgia | $195,000 | IV | Jan 2026 |
| Scientist IV, Avian Virology | Athens, Georgia | $130,000 | II | Aug 2025 |
| Scientist IV, Bioanalysis | Fulton, Missouri | $118,501 | III | Jun 2025 |
| Specialist, Lyo Equipment | Saint Joseph, Missouri | $90,000 | II | Jun 2025 |
| Product Portfolio Manager | Duluth, Georgia | $151,526 | III | Jun 2025 |
| SCIENTIST IV | Athens, Georgia | $143,252 | IV | May 2025 |
| Post Doctoral Fellow | Fulton, Missouri | $80,000 | I | Mar 2025 |
| Scientist IV, Clinical | Fulton, Missouri | $130,000 | II | Mar 2025 |
| Senior Specialist, QA Release | Athens, Georgia | $75,000 | IV | Mar 2025 |
| Senior Scientist, Clinical | Ames, Iowa | $145,000 | IV | Mar 2025 |
| Senior Scientist, Clinical | Athens, Georgia | $161,298 | IV | Mar 2025 |
| Director, Late Stage Drug Product Development | Athens, Georgia | $222,750 | III | Feb 2025 |
Source: U.S. Department of Labor OFLC certified Labor Condition Applications (H-1B, H-1B1, E-3), public disclosure data. Wages are employer-offered base pay and exclude bonuses, equity, and other compensation. Denied and withdrawn filings are excluded. Figures reflect filings decided Feb 2025–Mar 2026.
Compare across employers
For general educational purposes, not career or financial advice. Wages are employer-offered base pay from certified DOL LCA records and may differ from total compensation.